PENDARVIS DAVID 4
4 · RESMED INC · Filed Mar 7, 2023
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Sale
ResMed Common Stock
2023-03-03$216.69/sh−1,500$325,035→ 94,172 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022.